HB7581, the Living Organ Volunteer Engagement Act or “LOVE Act,” would create an 8-year Medicare demonstration program to pay eligible hospitals for the reasonable costs of operating living kidney donor transplant facilitator training programs. The bill is aimed at hospitals that perform kidney transplants and would support training individuals to help Medicare beneficiaries with end-stage renal disease identify prospective living kidney donors and navigate the kidney donation process.
The Secretary of Health and Human Services would be required to establish the program within 180 days of enactment and could waive Medicare provisions as needed to implement it. Hospitals participating in the demonstration would receive payment tied to their costs, and the program would be evaluated through reports to Congress after five years, with follow-up annual updates for two additional years. Those reports would measure changes in living kidney donation, transplant volume, patient outcomes, Medicare savings from reduced dialysis and increased transplants, and qualitative feedback from facilitators, volunteers, donors, and recipients.
Impact
The bill would amend section 1881 of the Social Security Act to add a new Medicare demonstration program focused on living kidney donor transplant facilitation. Its practical effect would be to authorize federal payment for a new hospital-based training function, potentially expanding transplant support services at hospitals that already perform kidney transplants. It would also create a formal reporting and evaluation structure for Congress to assess whether the program increases living donation and reduces Medicare costs associated with dialysis.
Sentiment
The bill appears generally supportive and bipartisan in tone, with sponsors from both parties and a policy goal centered on improving access to kidney transplants and encouraging living donation. Because there were no committee transcripts or recorded votes provided, there is no evidence of formal opposition in the available record. The structure of the bill suggests an experimental, evidence-gathering approach rather than a permanent expansion of Medicare benefits.
Contention
The main potential points of contention are likely to be the cost and scope of the Medicare demonstration, the Secretary’s authority to waive Medicare provisions, and whether the training program will produce measurable improvements in donation rates and outcomes. Some observers may question whether federal payment for facilitator training is the best use of Medicare funds, while supporters are likely to emphasize the possibility of fewer dialysis costs, more transplants, and better navigation support for patients with end-stage renal disease. No specific objections were recorded in the provided materials.